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Helicobacter pylori infection is common among adults with intellectual disability. The acceptabilities and
accuracies of different diagnostic tests in this population are unknown. We aimed to determine (i) patient
acceptability and (ii) performance characteristics of serology, fecal-antigen, and urea breath tests among
adults with intellectual disability. One hundred sixty-eight such adults underwent H. pylori testing with
serology and fecal-antigen tests, and a portion underwent treatment. One year later, the participants were
retested with fecal-antigen, serology, and urea breath tests. The numbers of specimens obtained and difficulties
in collection reported by caregivers were noted. Test performance characteristics were assessed among par-
ticipants and 65 of their caregivers, using serology as the reference. All participants provided at least one
specimen, despite reported collection difficulties for 23% of fecal and 27% of blood specimens. Only 25% of the
participants provided breath specimens; failure to perform this test was associated with lower intellectual
ability and higher maladaptive behavior. The sensitivity, specificity, and positive and negative predictive values
of the fecal test (baseline and 12 months versus caregivers) were 70 and 63 versus 81, 93 and 95 versus 98, 96
and 92 versus 93, and 53 and 74 versus 93%, respectively; those of the urea breath test (12 months versus
caregivers) were 86 versus 100, 88 versus 95, 75 versus 89, and 94 versus 100%, respectively. With assistance,
fecal or blood specimens for H. pylori assessment can be provided by most patients with intellectual disability
regardless of their level of function or behavior. Only those with greater ability can perform the urea breath
test. Using serology as the reference test, the limitations of performance characteristics of the fecal-antigen and
urea breath tests are similar to those among a control group of caregivers.
Selection of the most appropriate investigation to diagnose
Helicobacter pylori infection or to assess its eradication is in-
fluenced by the acceptability of the test to the patient, the
accuracy of the particular test, the prevalence of H. pylori
within the population, the current medications of the person
being tested, and the cost. Noninvasive tests for H. pylori di-
agnosis include serology, urea breath, and fecal-antigen test-
ing, while endoscopy allows biopsy specimen collection for
histology, rapid urease testing, PCR techniques, or culture.
The breath test is the preferred noninvasive test for H. pylori
among the general population in Western countries.
H. pylori infection is particularly relevant among adults with
intellectual disability because of its high prevalence, particu-
larly among those with a history of institutionalization (2, 4, 12,
22). In Australia, these individuals have a rate of infection up
to three times that among other Australian adults (13). The
prevalence among those who have never been institutionalized
also appears to be greater than that among their age-matched
nondisabled peers (22). Additional independent risk factors
for infection among adults with intellectual disability include
greater levels of disability and maladaptive behaviors and living
with flatmates with fecal incontinence or oral hypersalivation
(22). There is also substantial, but indirect, evidence that the
consequences of H. pylori infection, peptic ulcer disease (5, 11)
and gastric cancer (7), also occur more frequently among
members of the population with intellectual disability.
The assessment of H. pylori infection presents particular
problems among the population with intellectual disability with
respect to test accuracy and patient acceptability. The perfor-
mance characteristics of some tests may be adversely affected
among institutionalized populations with, for example, false
positives in serological assays due to cross-reactivity with other
common antibodies in the population (such as Campylobacter
jejuni [2]). The urea breath test may also be prone to inaccu-
racy due to polypharmacy, a common problem among people
with intellectual disability (18) which affects the gastrointesti-
nal milieu.
The presence of cognitive or functional impairments may
also place limitations on the acceptability of the various H.
pylori tests. For adults with intellectual disability, these factors
have been shown to impede the usual processes of investiga-
tion through associated limitations in decision-making skills
(9), behavioral problems (17), inability to cooperate (20), pres-
ence of fear and anxiety (10), financial and time constraints
(25), and poor understanding by health professionals (3).
In the majority of published studies of H. pylori infection
conducted among people with intellectual disability, investiga-
tors have used only serological means to diagnose infection,
and none have used the fecal-antigen or the urea breath test (2,
4, 12). Given the significance of H. pylori infection among
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adults with intellectual disability and the potential difficulties
in H. pylori investigations, the aim of this study was to identify
the most appropriate tests for H. pylori infection in such adults.
The present paper is one of a series of papers in which the
risk factors for and consequences of H. pylori infection, erad-
ication rates, and side effects among adults with intellectual
disability, and the prevalence of infection among their caregiv-
ers, were evaluated (22–24).
MATERIALS AND METHODS
The study population comprised 168 adults with intellectual disability who
lived in a single long-term residential facility, in group homes, or with family and
65 of their caregivers (including six nurses). The methods of participant recruit-
ment and consent procedures have been described in detail elsewhere (22). In
brief, all patients (n  195) who attended a tertiary-level outpatient clinic for
adults with intellectual disability in 1998 and who lived within 100 km of Brisbane
were invited to participate in the study through their statutory health attorney.
The statutory health attorneys of all 75 adult residents of a single institution, 53
adults who had previously been institutionalized, and 40 adults who had never
been institutionalized consented. All of the caregivers (200) of the participants
with intellectual disability were also invited to participate, and 65 enrolled (23).
The ethics committee of the University of Queensland and management staff
from the long-term residence approved the study.
From January to March 2000, all 168 participants with intellectual disability
underwent a biopsychosocial evaluation, including assessment of the level of
functional disability (using the Adaptive Behavior Scale part I [ABS I] [16]) and
maladaptive behavior (using the ABS II [16]), H. pylori treatment history, and H.
pylori infection status by the fecal-antigen test and serology. If any participant
had alarm symptoms or iron deficiency anemia, they were referred for endos-
copy. Twelve months later, the remaining 163 (97%) participants were reevalu-
ated and retested for H. pylori using the carbon-14 urea breath test in addition to
the fecal antigen and serology tests. A portion of the participants had received
eradication therapy between the two test points. The 65 caregivers were also
tested for H. pylori infection using all three tests.
At both time points, caregivers were asked to assist in specimen collection
from their clients, and at follow-up they were questioned about the difficulty of
this. If sedation or three or more attempts were required for collection of the
fecal or blood specimens, then the collection was classified as “difficult.” If the
participant was incontinent of feces, the collection was classified as “not diffi-
cult,” even if the fecal specimen was not obtained. If the participant could not
fast or was unable to perform the breath test on the first attempt, the test was
considered unacceptable for that participant.
Investigations. The fecal-antigen test selected for the study was the Premier
Platinum HpSA (Meridian Diagnostics, Cincinnati, Ohio). For this test, each
participant was required to provide a peanut-size sample of feces. The manu-
facturer’s published performance characteristics among test populations in
whom the prevalence of H. pylori infection was50% were as follows: sensitivity,
96%; specificity, 96%; positive predictive value, 96%; and negative predictive
value, 96%. This test had not previously been evaluated for use among adults
with intellectual disability. The intended uses of the test according to the man-
ufacturer include diagnosis and assessment of eradication of H. pylori after
treatment, although there is controversy over its accuracy as a test of eradication
(8). All the tests were performed by the same laboratory according to the
manufacturer’s specifications.
The pylori DTect ELISA (Diagnostic Technology, Sydney, Australia), an en-
zyme-linked immunosorbent assay which detects anti-H. pylori immunoglobulin
G antibodies, was selected as the most appropriate serum assay for this study.
The assay has been validated among populations from developing countries and
Australia, with reported sensitivity and specificity rates of 96 and 93%, respec-
tively, and among a population in whom the rate of infection was 50%, with
positive and negative predictive values of 94 and 96%, respectively (26). Its main
indication is the diagnosis of H. pylori infection for patients who have never been
treated for H. pylori infection. Unlike the fecal-antigen test, the result is valid
when the patient is taking or has recently completed a course of antibiotics or is
taking a proton pump inhibitor. For the test, each participant was required to
provide blood by venesection. Serum specimens were analyzed twice at baseline
at the laboratory which manufactured the test. At 12 months, serum specimens
were analyzed at a local laboratory using the same assay. If a 12-month result
differed from baseline, both samples were reanalyzed, and if a different result was
obtained, the test was rerun a third time and a consensus decision was made.
The carbon-14 urea breath test was developed by the local laboratory based on
the methods described by Marshall and colleagues (15). It is used commercially
by the laboratory and is subject to monthly quality assurance checks. Each
participant was required to fast prior to the test, drink 20 ml of water containing
radioactive-carbon-14-labeled urea, wait 20 min, and then blow into a small tube
containing CO2 trapping solution until an indicator changed color.
In most studies, the “gold standard” for H. pylori testing is derived from a
combination of tests requiring endoscopy—such as histology, culture, or Campy-
lobacter-like-organism testing—or the urea breath test. In the present study,
neither of these approaches could be used as the gold standard because it was
predicted that only a minority of participants would be able to perform the
breath test and it would have been unethical to submit all participants to re-
peated endoscopy. The H. pylori fecal-antigen test had not been locally validated
and was not commonly used in Australian laboratories at the start of the study,
so the serological assay was selected as the proxy gold standard. The limitation
of this selection was that results could be compared only among participants who
had not previously been treated for H. pylori. Participants who had taken anti-
biotics in the previous 2 weeks or who were currently taking a proton pump
inhibitor were also excluded from test comparison because the fecal and breath
tests are not valid in this group. These limitations implied that the fecal-antigen
results could be compared with serology for 101 and 40 participants with intel-
lectual disability at baseline and 12 months, respectively, and 59 caregivers. Urea
breath test results could be compared with serology for 24 participants with
intellectual disability and 60 caregivers.
Data analysis. To assess the acceptability of the H. pylori tests, the numbers of
specimens provided and caregiver-reported difficulties in specimen collection
were noted. Participants were partitioned into lower (below-average ABS factor
scores, indicating more severe disability or maladaptive behavior) and higher
(average and above-average ABS factor scores, indicating less disability or mal-
adaptive behavior) functional-ability and maladaptive-behavior categories and
assessed for inability to provide a specimen. Fisher’s exact test was used to
compare the groups. A significance level of 0.05 was used for all statistical
calculations. Using serology as the reference, sensitivity, specificity, positive and
negative predictive values, and associated exact 95% confidence intervals (CI)
(1) were calculated for the fecal-antigen test and the urea breath test among both
participants and caregivers.
RESULTS
At baseline, all 168 participants with intellectual disability
provided either a fecal or blood specimen for H. pylori evalu-
ation and were able to be classified with respect to H. pylori
status. At 12 months, 162 (99%) of the remaining 163 partic-
ipants (1 died, 3 withdrew, and 1 was acutely ill) provided fecal,
blood, and/or breath specimens, and 159 (98%) could be clas-
sified with respect to H. pylori status. Three could not be
classified because they had received H. pylori eradication treat-
ment and provided only blood for serology testing. The per-
centages of participants who could provide fecal samples at
baseline and 12 months (91 versus 94%) were similar, as were
those who could provide blood specimens (89 versus 94%)
(Table 1). At 12 months, 27% of the participants with intel-
lectual disability provided a breath specimen.
Caregivers reported that while there were some difficulties
in either blood (27%) or feces (23%) specimen collection from
their clients, they were still able to collect specimens in the
majority (78 and 74%, respectively) of these cases (Table 2).
Strategies reported by caregivers to obtain the specimens in-
cluded negotiation, sedation, or turning off the toilet water to
retrieve the fecal specimen. There was a small portion of par-
ticipants with intellectual disability for whom there were no
reported difficulties in specimen collection, yet specimens were
not obtained. The reasons for noncollection of specimens were
not available.
There was no evidence to suggest that inability to obtain
fecal or blood specimens from participants with intellectual
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disability was significantly influenced by their levels of func-
tional ability or maladaptive behavior (Table 3). In contrast,
the inability to perform the urea breath test was strongly pos-
itively associated with greater levels of disability and, to a lesser
degree, greater levels of maladaptive behavior. At baseline,
more institutionalized participants did not provide a fecal spec-
imen than previously institutionalized participants, who in turn
were more likely not to provide a fecal specimen than partic-
ipants who were never institutionalized (15 versus 8 versus 0%,
respectively; P  0.03), but at 12 months, there were no dif-
ferences in the abilities of participants from any of the three
institutional categories to provide fecal or blood specimens.
Table 4 shows the performance characteristics of the fecal-
antigen test results compared to the serology results (including
only participants or caregivers with no prior treatment, recent
antibiotics, or current proton pump inhibitors) at the two time
points for participants with intellectual disability and at the
single time point for caregivers. For the participants with in-
tellectual disability, the sensitivities at baseline and 12 months
were lower than among the caregivers (70 and 63 versus 81%,
respectively), although all CI overlapped. The negative predic-
tive value was lowest among the participants with intellectual
disability at baseline (53%), where the prevalence of H. pylori
infection was 74%, but was higher in the participants at 12
months (74%), when the prevalence of H. pylori infection had
fallen to 48%, and in caregivers (93%), where the prevalence
of H. pylori infection was 27%. The specificity and positive
predictive values were similar for participants with intellectual
disability tested at baseline and 12 months and for caregivers.
Table 4 also shows the performance characteristics of the
carbon-14 urea breath test compared to serology. Among care-
givers and participants with intellectual disability who per-
formed this test, the prevalences of H. pylori were similar (27
versus 28%, respectively). The estimated sensitivity, specificity,
and positive and negative predictive values were all slightly
lower among participants with intellectual disability than
among caregivers. Among both caregivers and participants
with intellectual disability, the urea breath test appeared to
perform with better sensitivity and negative predictive values
but lower specificity and positive predictive values than the
fecal-antigen test.
DISCUSSION
Our analysis has contributed two main findings to the dis-
cussion of how to manage H. pylori infection among adults with
intellectual disability. First, it has shown that no patient with
intellectual disability need be excluded from H. pylori testing or
treated empirically on the basis that he or she cannot be tested
for the infection. The fecal-antigen and serology tests were
found to be equally acceptable to adults with intellectual dis-
ability, regardless of their level of intellectual disability or
maladaptive behavior. Although not all participants could pro-
vide both specimens for both tests, if fecal-specimen provision
was unacceptable or a fecal test was inappropriate because of
other medication, provision of a blood specimen would be an
acceptable alternative for diagnosis, or vice versa, subject to
the standard restrictions of either test. It should be noted,
however, that for about a quarter of these participants, care-
giver motivation was required to assist in fecal or blood spec-
imen collection, as without caregiver assistance and effort, the
numbers of participants who would not provide specimens
spontaneously would have been much higher. For those people
with higher ability, the urea breath test is another option for
diagnosis. The inverse relationship between ability to perform
the breath test and level of intellectual disability was not sur-
prising and was consistent with data showing that this test
cannot be performed by younger children due to the technical
requirements of the test (19).
Secondly, using the pylori DTect serology assay as the refer-
ence test, and with parallel calculation of the performance
characteristics among caregivers, the study highlighted some
limitations of the use of fecal-antigen and urea breath test
results among adults with intellectual disability, but overall, it
suggested that these tests are adequately reliable in both study
populations. The high concordance among the fecal-antigen,
urea breath, and serology test results among caregivers seemed
to vindicate the choice of the serology assay as a reference test.
Moreover, the performance characteristics of both tests among
caregivers were well within conventional clinical and labora-
tory standards of accuracy, supporting the general use of these
assays for H. pylori diagnosis in the community. It must be
noted, however, that different results could be obtained by
other serological assays, as serological results may be influ-
enced by the prevalence of infection, underlying diseases and
medications of the test group, and age and ethnic background
of the test population (14). The consistency of the performance
TABLE 1. Numbers and percentages of participants with
intellectual disability who provided specimens for H. pylori
evaluation at baseline and at 12 months
Test
No. (%) of participants
Baseline
(n  168)
12 months
(n  163)
Serology
Only test done 15 (9) 5 (3)
Total no. tested 149 (89) 151 (93)
Fecal antigen
Only test done 19 (11) 7 (4)
Total no. tested 153 (91) 153 (94)
Carbon-14 urea breath
Only test done Not offered 2 (1)
Total no. tested Not offered 44 (27)
Total no. who did not provide
any specimen
0 (0) 1 (1)
TABLE 2. Numbers and percentages of 166a participants who had
specimens collected for H. pylori assessment by caregivers’
perceptions of degree of difficulty in obtaining
the specimen at baseline
Difficulty
obtaining test Total no. (%)
No. (%) of specimens
collected
Feces
Difficult 38 of 166 (23) 28 of 38 (74)
Not difficult 128 of 166 (77) 123 of 128 (96)
Blood
Difficult 45 of 166 (27) 36 of 45 (80)
Not difficult 121 of 166 (73) 113 of 121 (93)
a Information not known for two participants.
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of such assays should therefore be established in a particular
geographical and regional setting.
The specificities of the fecal-antigen and urea breath tests
among the participants with intellectual disability were not
much lower than those among the caregivers and were gener-
ally comparable to other published figures (15, 21). The sen-
sitivities of both tests, and particularly the fecal-antigen test,
were somewhat lower among participants with intellectual dis-
ability than among the caregivers, although 95% CI for all
values overlapped. There may be subtle difficulties in the
breath test technique among those with intellectual disability
or factors, such as the high medication rate in the group, that
might alter the gastric milieu affecting fecal-assay perfor-
mance. The lower negative predictive value of the fecal-anti-
gen test among participants with intellectual disability at base-
line compared to their results at 12 months and those of the
caregivers may have been a consequence of the higher preva-
lence of infection in this group at baseline (74 versus 48 and
28%, respectively).
These findings suggest that use of the fecal-antigen or urea
breath test among adults with intellectual disability is generally
reliable, but they do highlight a need for caution in the inter-
pretation of test results. For adults with intellectual disability,
a positive fecal-antigen test result would appear to be very
reliable, but there is a greater risk of a false-negative test
result. Using the urea breath test, a negative test result would
appear to be very reliable, but there is a higher risk of a
false-positive test result. No test is perfect, and when clinical
suspicion or strong risk factors exist, consideration should be
given to repeating the test or conducting an alternative diag-
nostic test if an initial test result is negative.
Although not assessed in the present paper, the acceptability
and accuracy of the fecal-antigen test for the majority of par-
ticipants with intellectual disability imply that this test may also
be suitable to assess the effectiveness of H. pylori eradication
therapy. The urea breath test may also be considered with
reasonable confidence as a test of H. pylori treatment success
among those adults with lower levels of intellectual disability.
In conclusion, the present study evaluated the acceptability,
tolerability, and accuracy of three noninvasive tests for the
TABLE 3. Numbers and percentages of participants with lower or higher levels of intellectual disability or maladaptive behavior who could
not perform the breath test or provide a fecal or blood specimen at 12 months
ABS
No. (%) of participantsb
Factor levela Total No breath testsample P
No fecal-antigen
sample P
No serology
sample P
I Personal self-sufficiency
Lower 41 41 (100) 0 (0) 3 (7)
Higher 121 75 (62) 0.01 10 (8) 0.07 9 (7) 1.00
Community self-sufficiency
Lower 105 101 (96) 5 (5) 7 (7)
Higher 57 15 (26) 0.01 5 (9) 0.32 5 (9) 0.76
Personal-social responsibility
Lower 90 88 (98) 4 (4) 5 (6)
Higher 70 28 (40) 0.01 6 (9) 0.34 7 (10) 0.37
II Social adjustment
Lower 83 62 (75) 7 (8) 5 (6)
Higher 78 52 (67) 0.23 3 (4) 0.33 7 (9) 0.56
Personal adjustment
Lower 99 79 (80) 8 (8) 10 (10)
Higher 62 35 (56) 0.01 2 (3) 0.32 2 (3) 0.13
a “Lower” means more severe level of intellectual disability or maladaptive behavior.
b P values calculated by Fisher’s exact test.
TABLE 4. Sensitivity, specificity, positive predictive value, and negative predictive value of fecal-antigen and urea breath tests compared to
serology test (treated as the gold standard)
Test Group No.testeda
No. of
true
positives
(serology)
No. of
false
positives
No. of
true
negatives
(serology)
No. of
false
negatives
% Sensitivity
(95% CI)
% Specificity
(95% CI)
% Positive
predictive
value
(95% CI)
% Negative
predictive
value
(95% CI)
Fecal antigen Participants with intellectual
disability at baseline
101 74 2 27 22 70 (59, 80) 93 (76, 99) 96 (87, 100) 53 (38, 68)
Participants with intellectual
disability at 12 months
40 19 1 21 7 63 (38, 84) 95 (76, 100) 92 (64, 100) 74 (54, 89)
Caregivers 59 16 43 43 3 81 (54, 96) 98 (88, 100) 93 (66, 100) 93 (82, 99)
Urea breath Participants with intellectual
disability at 12-months
24 7 2 17 1 86 (42, 100) 88 (64, 99) 75 (35, 97) 94 (70, 100)
Caregivers 60 16 2 44 0 100 (79, 100) 95 (85, 99) 89 (65, 99) 100 (92, 100)
a Includes only those never treated for H. pylori and not taking proton pump inhibitors or recent antibiotics.
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diagnosis of H. pylori infection among adults with intellectual
disability, in whom the infection and disease consequences are
common. Both the fecal-antigen and serology tests are toler-
ated by the majority of adults with intellectual disability with a
range of severe to mild disability and maladaptive behavior,
given appropriate caregiver support. The urea breath test is
also able to be performed by more than half of those with
milder levels of disability. Using a locally validated serology
test, the fecal-antigen and urea breath tests have acceptable
sensitivity, specificity, and positive and negative predictive val-
ues, although there is a tendency for the fecal-antigen test to
miss infection and for the urea breath test to overestimate
infection. None of the three tests assessed in the present study
is recommended for use in any patient who has alarm symp-
toms and signs (prolonged unexplained vomiting, iron defi-
ciency anemia, melena, or hematemesis) or a complaint of
dyspepsia for the first time if over 45 years of age; in these
cases, endoscopy is the appropriate first-line investigation (6).
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